Tower Research Capital LLC (Trc) Alpine Immune Sciences, Inc. Transaction History

Tower Research Capital LLC (Trc)

$5.8 Billion
Q2 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$17.75 - $41.6 $84,827 - $198,806	-4,779 Reduced 87.05%	711 $28,000
Q4 2023 Feb 13, 2024	BUY	$8.54 - $20.22 $37,721 - $89,311	4,417 Added 411.65%	5,490 $104,000
Q3 2023 Nov 14, 2023	BUY	$10.13 - $13.98 $405 - $559	40 Added 3.87%	1,073 $12,000
Q2 2023 Aug 14, 2023	SELL	$6.84 - $11.91 $3,187 - $5,550	-466 Reduced 31.09%	1,033 $10,000
Q1 2023 May 09, 2023	BUY	$7.0 - $8.75 $3,346 - $4,182	478 Added 46.82%	1,499 $12,000
Q4 2022 Feb 10, 2023	SELL	$5.45 - $7.35 $3,177 - $4,285	-583 Reduced 36.35%	1,021 $8,000
Q3 2022 Nov 10, 2022	SELL	$6.89 - $9.39 $135,078 - $184,090	-19,605 Reduced 92.44%	1,604 $12,000
Q2 2022 Aug 15, 2022	BUY	$6.71 - $9.52 $128,865 - $182,831	19,205 Added 958.33%	21,209 $180,000
Q1 2022 May 12, 2022	BUY	$6.41 - $13.89 $7,685 - $16,654	1,199 Added 148.94%	2,004 $18,000
Q4 2021 Feb 14, 2022	SELL	$10.41 - $13.95 $12,315 - $16,502	-1,183 Reduced 59.51%	805 $11,000
Q3 2021 Nov 15, 2021	BUY	$8.19 - $11.31 $10,434 - $14,408	1,274 Added 178.43%	1,988 $21,000
Q2 2021 Aug 16, 2021	SELL	$8.81 - $15.03 $2,475 - $4,223	-281 Reduced 28.24%	714 $7,000
Q1 2021 May 17, 2021	BUY	$10.02 - $13.92 $7,064 - $9,813	705 Added 243.1%	995 $10,000
Q4 2020 Feb 16, 2021	SELL	$7.42 - $15.96 $99,094 - $213,145	-13,355 Reduced 97.87%	290 $4,000
Q3 2020 Nov 16, 2020	BUY	$7.15 - $11.5 $96,296 - $154,882	13,468 Added 7609.04%	13,645 $120,000
Q2 2020 Aug 13, 2020	BUY	$2.77 - $12.1 $490 - $2,141	177 New	177 $2,000
Q4 2019 Feb 07, 2020	SELL	$2.45 - $3.87 $218 - $344	-89 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$3.5 - $5.0 $311 - $445	89 New	89 $0
Q2 2019 Aug 13, 2019	SELL	$4.08 - $7.75 $2,582 - $4,905	-633 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$4.09 - $7.19 $9,660 - $16,982	-2,362 Reduced 78.86%	633 $4,000
Q4 2018 Feb 14, 2019	BUY	$3.68 - $6.07 $6,403 - $10,561	1,740 Added 138.65%	2,995 $11,000
Q3 2018 Nov 13, 2018	SELL	$5.68 - $8.59 $465 - $704	-82 Reduced 6.13%	1,255 $8,000
Q2 2018 Aug 15, 2018	BUY	$7.16 - $10.05 $8,885 - $12,472	1,241 Added 1292.71%	1,337 $10,000
Q1 2018 May 15, 2018	SELL	$7.95 - $11.65 $6,272 - $9,191	-789 Reduced 89.15%	96 $1,000
Q4 2017 Feb 09, 2018	BUY	$9.65 - $12.65 $8,540 - $11,195	885	885 $10,000

Others Institutions Holding ALPN

# of Institutions

Shares Held

56.2K

Call Options Held

Put Options Held

View Full List

About ALPINE IMMUNE SCIENCES, INC.

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

More about ALPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account